Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

PDEX vs DBVT vs ALKS vs NSYS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
PDEX
Pro-Dex, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$184M
5Y Perf.+191.5%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.-58.8%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.90B
5Y Perf.+116.4%
NSYS
Nortech Systems Incorporated

Hardware, Equipment & Parts

TechnologyNASDAQ • US
Market Cap$35M
5Y Perf.+272.6%

PDEX vs DBVT vs ALKS vs NSYS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
PDEX logoPDEX
DBVT logoDBVT
ALKS logoALKS
NSYS logoNSYS
IndustryMedical - Instruments & SuppliesBiotechnologyBiotechnologyHardware, Equipment & Parts
Market Cap$184M$1712.35T$5.90B$35M
Revenue (TTM)$75M$0.00$1.56B$117M
Net Income (TTM)$12M$-168M$153M$-3M
Gross Margin27.8%65.4%13.5%
Operating Margin14.5%12.3%-1.0%
Forward P/E24.1x24.8x
Total Debt$17M$22M$70M$18M
Cash & Equiv.$419K$194M$1.12B$916K

PDEX vs DBVT vs ALKS vs NSYSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

PDEX
DBVT
ALKS
NSYS
StockMay 20May 26Return
Pro-Dex, Inc. (PDEX)100291.5+191.5%
DBV Technologies S.… (DBVT)10041.2-58.8%
Alkermes plc (ALKS)100216.4+116.4%
Nortech Systems Inc… (NSYS)100372.6+272.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: PDEX vs DBVT vs ALKS vs NSYS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: PDEX leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. DBV Technologies S.A. is the stronger pick specifically for recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
PDEX
Pro-Dex, Inc.
The Income Pick

PDEX carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 1 yrs, beta 0.33
  • Rev growth 23.7%, EPS growth 345.0%, 3Y rev CAGR 16.6%
  • 14.2% 10Y total return vs NSYS's 233.9%
  • Lower volatility, beta 0.33, Low D/E 45.3%, current ratio 3.23x
Best for: income & stability and growth exposure
DBVT
DBV Technologies S.A.
The Momentum Pick

DBVT is the #2 pick in this set and the best alternative if momentum is your priority.

  • +110.4% vs ALKS's +16.5%
Best for: momentum
ALKS
Alkermes plc
The Quality Angle

ALKS plays a supporting role in this comparison — it may shine differently against other peers.

Best for: healthcare exposure
NSYS
Nortech Systems Incorporated
The Lower-Volatility Pick

NSYS lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: technology exposure
See the full category breakdown
CategoryWinnerWhy
GrowthPDEX logoPDEX23.7% revenue growth vs DBVT's -100.0%
ValuePDEX logoPDEXBetter valuation composite
Quality / MarginsPDEX logoPDEX16.1% margin vs NSYS's -2.3%
Stability / SafetyPDEX logoPDEXBeta 0.33 vs DBVT's 1.26
DividendsTieNone of these 4 stocks pay a meaningful dividend
Momentum (1Y)DBVT logoDBVT+110.4% vs ALKS's +16.5%
Efficiency (ROA)PDEX logoPDEX18.3% ROA vs DBVT's -89.0%

PDEX vs DBVT vs ALKS vs NSYS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

PDEXPro-Dex, Inc.
FY 2013
Non Warranty Repairs
100.0%$722,000
DBVTDBV Technologies S.A.

Segment breakdown not available.

ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
NSYSNortech Systems Incorporated
FY 2013
Industrial
50.2%$56M
Medical
31.9%$35M
Aerospace and Defense
17.9%$20M

PDEX vs DBVT vs ALKS vs NSYS — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLPDEXLAGGINGDBVT

Income & Cash Flow (Last 12 Months)

ALKS leads this category, winning 3 of 6 comparable metrics.

ALKS and DBVT operate at a comparable scale, with $1.6B and $0 in trailing revenue. PDEX is the more profitable business, keeping 16.1% of every revenue dollar as net income compared to NSYS's -2.3%. On growth, ALKS holds the edge at +28.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricPDEX logoPDEXPro-Dex, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcNSYS logoNSYSNortech Systems I…
RevenueTrailing 12 months$75M$0$1.6B$117M
EBITDAEarnings before interest/tax$13M-$112M$212M$166,000
Net IncomeAfter-tax profit$12M-$168M$153M-$3M
Free Cash FlowCash after capex$7M-$151M$392M-$3M
Gross MarginGross profit ÷ Revenue+27.8%+65.4%+13.5%
Operating MarginEBIT ÷ Revenue+14.5%+12.3%-1.0%
Net MarginNet income ÷ Revenue+16.1%+9.8%-2.3%
FCF MarginFCF ÷ Revenue+9.5%+25.1%-2.5%
Rev. Growth (YoY)Latest quarter vs prior year+14.6%+28.2%-2.9%
EPS Growth (YoY)Latest quarter vs prior year+22.4%+91.5%-4.1%+81.5%
ALKS leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

NSYS leads this category, winning 2 of 4 comparable metrics.

At 21.5x trailing earnings, PDEX trades at a 13% valuation discount to ALKS's 24.8x P/E. On an enterprise value basis, PDEX's 16.8x EV/EBITDA is more attractive than NSYS's 33.7x.

MetricPDEX logoPDEXPro-Dex, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcNSYS logoNSYSNortech Systems I…
Market CapShares × price$184M$1712.35T$5.9B$35M
Enterprise ValueMkt cap + debt − cash$200M$1712.35T$4.9B$52M
Trailing P/EPrice ÷ TTM EPS21.51x-0.76x24.76x-26.64x
Forward P/EPrice ÷ next-FY EPS est.24.13x
PEG RatioP/E ÷ EPS growth rate1.76x
EV / EBITDAEnterprise value multiple16.79x17.25x33.70x
Price / SalesMarket cap ÷ Revenue2.76x4.00x0.27x
Price / BookPrice ÷ Book value/share5.27x0.66x3.28x1.02x
Price / FCFMarket cap ÷ FCF12.28x
NSYS leads this category, winning 2 of 4 comparable metrics.

Profitability & Efficiency

ALKS leads this category, winning 5 of 9 comparable metrics.

PDEX delivers a 29.1% return on equity — every $100 of shareholder capital generates $29 in annual profit, vs $-130 for DBVT. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to NSYS's 0.53x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs NSYS's 2/9, reflecting strong financial health.

MetricPDEX logoPDEXPro-Dex, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcNSYS logoNSYSNortech Systems I…
ROE (TTM)Return on equity+29.1%-130.2%+8.8%-7.9%
ROA (TTM)Return on assets+18.3%-89.0%+5.4%-3.5%
ROICReturn on invested capital+17.0%+18.9%-0.3%
ROCEReturn on capital employed+24.8%-145.7%+14.2%-0.4%
Piotroski ScoreFundamental quality 0–96472
Debt / EquityFinancial leverage0.45x0.13x0.04x0.53x
Net DebtTotal debt minus cash$16M-$172M-$1.0B$17M
Cash & Equiv.Liquid assets$419,000$194M$1.1B$916,000
Total DebtShort + long-term debt$17M$22M$70M$18M
Interest CoverageEBIT ÷ Interest expense32.18x-189.82x32.30x-1.23x
ALKS leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

PDEX leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in NSYS five years ago would be worth $20,325 today (with dividends reinvested), compared to $3,090 for DBVT. Over the past 12 months, DBVT leads with a +110.4% total return vs ALKS's +16.5%. The 3-year compound annual growth rate (CAGR) favors PDEX at 54.0% vs ALKS's 4.6% — a key indicator of consistent wealth creation.

MetricPDEX logoPDEXPro-Dex, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcNSYS logoNSYSNortech Systems I…
YTD ReturnYear-to-date+52.2%+4.9%+25.3%+68.5%
1-Year ReturnPast 12 months+34.4%+110.4%+16.5%+29.7%
3-Year ReturnCumulative with dividends+265.5%+19.7%+14.5%+25.5%
5-Year ReturnCumulative with dividends+67.1%-69.1%+60.9%+103.2%
10-Year ReturnCumulative with dividends+1423.1%-87.0%-11.0%+233.9%
CAGR (3Y)Annualised 3-year return+54.0%+6.2%+4.6%+7.9%
PDEX leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

PDEX leads this category, winning 2 of 2 comparable metrics.

PDEX is the less volatile stock with a 0.33 beta — it tends to amplify market swings less than DBVT's 1.26 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PDEX currently trades 97.0% from its 52-week high vs DBVT's 76.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricPDEX logoPDEXPro-Dex, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcNSYS logoNSYSNortech Systems I…
Beta (5Y)Sensitivity to S&P 5000.33x1.26x1.06x0.50x
52-Week HighHighest price in past year$59.22$26.18$36.60$15.39
52-Week LowLowest price in past year$23.47$7.53$25.17$6.50
% of 52W HighCurrent price vs 52-week peak+97.0%+76.3%+96.7%+81.4%
RSI (14)Momentum oscillator 0–10069.248.160.249.2
Avg Volume (50D)Average daily shares traded26K252K2.3M20K
PDEX leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — PDEX and NSYS each lead in 1 of 1 comparable metric.

Analyst consensus: PDEX as "Buy", DBVT as "Buy", ALKS as "Buy". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs 24.3% for ALKS (target: $44).

MetricPDEX logoPDEXPro-Dex, Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcNSYS logoNSYSNortech Systems I…
Analyst RatingConsensus buy/hold/sellBuyBuyBuy
Price TargetConsensus 12-month target$46.33$44.00
# AnalystsCovering analysts11528
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises1001
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+1.9%0.0%+0.5%+0.3%
Evenly matched — PDEX and NSYS each lead in 1 of 1 comparable metric.
Key Takeaway

ALKS leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PDEX leads in 2 (Total Returns, Risk & Volatility). 1 tied.

Best OverallPro-Dex, Inc. (PDEX)Leads 2 of 6 categories
Loading custom metrics...

PDEX vs DBVT vs ALKS vs NSYS: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is PDEX or DBVT or ALKS or NSYS a better buy right now?

For growth investors, Pro-Dex, Inc.

(PDEX) is the stronger pick with 23. 7% revenue growth year-over-year, versus -8. 0% for Nortech Systems Incorporated (NSYS). Pro-Dex, Inc. (PDEX) offers the better valuation at 21. 5x trailing P/E (24. 1x forward), making it the more compelling value choice. Analysts rate Pro-Dex, Inc. (PDEX) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — PDEX or DBVT or ALKS or NSYS?

On trailing P/E, Pro-Dex, Inc.

(PDEX) is the cheapest at 21. 5x versus Alkermes plc at 24. 8x.

03

Which is the better long-term investment — PDEX or DBVT or ALKS or NSYS?

Over the past 5 years, Nortech Systems Incorporated (NSYS) delivered a total return of +103.

2%, compared to -69. 1% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: PDEX returned +1423% versus DBVT's -87. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — PDEX or DBVT or ALKS or NSYS?

By beta (market sensitivity over 5 years), Pro-Dex, Inc.

(PDEX) is the lower-risk stock at 0. 33β versus DBV Technologies S. A. 's 1. 26β — meaning DBVT is approximately 287% more volatile than PDEX relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 53% for Nortech Systems Incorporated — giving it more financial flexibility in a downturn.

05

Which is growing faster — PDEX or DBVT or ALKS or NSYS?

By revenue growth (latest reported year), Pro-Dex, Inc.

(PDEX) is pulling ahead at 23. 7% versus -8. 0% for Nortech Systems Incorporated (NSYS). On earnings-per-share growth, the picture is similar: Pro-Dex, Inc. grew EPS 345. 0% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Over a 3-year CAGR, PDEX leads at 16. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — PDEX or DBVT or ALKS or NSYS?

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus -1. 0% for Nortech Systems Incorporated — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus -0. 2% for NSYS. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is PDEX or DBVT or ALKS or NSYS more undervalued right now?

Analyst consensus price targets imply the most upside for DBVT: 131.

8% to $46. 33.

08

Which pays a better dividend — PDEX or DBVT or ALKS or NSYS?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is PDEX or DBVT or ALKS or NSYS better for a retirement portfolio?

For long-horizon retirement investors, Pro-Dex, Inc.

(PDEX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 33), +1423% 10Y return). Both have compounded well over 10 years (PDEX: +1423%, DBVT: -87. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between PDEX and DBVT and ALKS and NSYS?

These companies operate in different sectors (PDEX (Healthcare) and DBVT (Healthcare) and ALKS (Healthcare) and NSYS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: PDEX is a small-cap high-growth stock; DBVT is a mega-cap quality compounder stock; ALKS is a small-cap quality compounder stock; NSYS is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

PDEX

Steady Growth Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Net Margin > 9%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

NSYS

Quality Business

  • Sector: Technology
  • Market Cap > $100B
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.